Phase II study of whole brain radiotherapy with concomitant cisplatinum and vinorelbine for breast cancer patients with brain metastasis.

被引：0
|
作者：
Lancry, L
Ray-Coquard, I
Gorain, C
Curé, H
Lortholary, A
Claude, L
Guastalla, JP
Biron, P
Gomez, F
Bachelot, T
机构：
[1] Ctr Leon Berard, F-69373 Lyon, France
[2] Ctr Jean Perrin, Clermont Ferrand, France
[3] Ctr Paul Papin, Angers, France
来源：
BREAST CANCER RESEARCH AND TREATMENT | 2004年 / 88卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：S170 / S170
页数：1
相关论文
共 50 条
  • [1] Metronomic oral vinorelbine and temozolomide, after whole brain radiotherapy, for the treatment of breast cancer patients with brain metastasis. A phase II study
    Addeo, R.
    Montella, L.
    Leo, G.
    De Rosa, C.
    Franco, A.
    Guarrasi, R.
    Faiola, V.
    Cennamo, G.
    Gargiulo, R.
    Del Prete, S.
    EJC SUPPLEMENTS, 2008, 6 (07): : 173 - 173
  • [2] METRONOMIC ORAL VINORELBINE AND TEMOZOLOMIDE, AFTER WHOLE BRAIN RADIOTHERAPY, FOR THE TREATMENT OF BREAST CANCER PATIENTS WITH BRAIN METASTASIS. A PHASE II STUDY
    Montella, Liliana
    Addeo, Raffaele
    Leo, Gino
    De Rosa, Carmine
    Cennamo, Gregorio
    Guarrasi, Rosario
    Faiola, Vincenzo
    Gargiulo, Raffaele
    Franco, Antonio
    Caraglia, Michele
    Del Prete, Salvatore
    EJC SUPPLEMENTS, 2008, 6 (14): : 116 - 116
  • [3] Phase II study of concurrent temozolomide and whole brain radiation therapy in patients with brain metastasis.
    Dawood, S.
    Ragaz, J.
    Navaratnam, S.
    Mihalcioiu, C.
    JOURNAL OF CLINICAL ONCOLOGY, 2006, 24 (18) : 68S - 68S
  • [4] Concomitant chemoradiotherapy (CCR) for brain metastasis. Results of a phase I-II study
    Mahjoubi, R
    Brugiere, O
    LeRol, A
    Llory, JF
    Vannetzel, JM
    EUROPEAN JOURNAL OF CANCER, 1997, 33 : 907 - 907
  • [5] Temozolomide and concomitant whole brain radiotherapy in patients with brain metastases:: A phase II randomized trial
    Verger, E
    Miguel, G
    Yaya, R
    Viñolas, N
    Villà, S
    Pujol, T
    Quintó, L
    Graus, F
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2005, 61 (01): : 185 - 191
  • [6] Phase II study of temozolomide and concomitant whole-brain radiotherapy in patients with brain metastases from solid tumors
    Kouvaris, John R.
    Miliadou, Anthi
    Kouloulias, Vassilis E.
    Kolokouris, Dimitrios
    Balafouta, Myrsini J.
    Papacharalampous, Xenofon N.
    Vlahos, Lambros J.
    ONKOLOGIE, 2007, 30 (07): : 361 - 366
  • [7] Whole-brain Radiation Therapy for Breast Cancer Patients with Dural Metastasis Without Concomitant Brain Metastasis and Leptomeningeal Metastasis
    Sakaguchi, Masakuni
    Maebayashi, Toshiya
    Aizawa, Takuya
    Ishibashi, Naoya
    ANTICANCER RESEARCH, 2018, 38 (11) : 6405 - 6411
  • [8] MRI evaluation of the effects of whole brain radiotherapy on breast cancer brain metastasis
    Crowe, William
    Wang, Lulu
    Zhang, Zhongwei
    Varagic, Jasmina
    Bourland, J. Daniel
    Chan, Michael D.
    Habib, Amyn A.
    Zhao, Dawen
    INTERNATIONAL JOURNAL OF RADIATION BIOLOGY, 2018, 95 (03) : 338 - 346
  • [9] Concomitant Application of Cyclooxygenase-2 Inhibitor and Whole Brain Radiotherapy in Patients with Brain Metastasis
    Bora, Huseyin
    Asikoglu, Haluk
    Akmansu, Muge
    Erpolat, Ozge Petek
    GAZI MEDICAL JOURNAL, 2012, 23 (03): : 70 - 76
  • [10] Multicenter study for breast cancer brain metastasis: Role of whole-brain radiotherapy (KROG 1612)
    Kim, J. S.
    Kim, K.
    Jung, W.
    Shin, K. H.
    Im, S.
    Kim, H.
    Kim, Y. B.
    Chang, J. S.
    Kim, J. H.
    Choi, D. H.
    Park, Y. H.
    Kim, D. Y.
    Kim, T. H.
    Choi, B. O.
    Lee, S.
    Kim, S.
    Kwon, J.
    Kang, K. M.
    Chung, W.
    Kim, K. S.
    Yoon, W. S.
    Cha, J.
    Oh, Y. K.
    Kim, I. A.
    RADIOTHERAPY AND ONCOLOGY, 2021, 161 : S882 - S883
12345